HOME >> MEDICINE >> NEWS
OneWorld Health licenses compounds from Yale, U of Washington to treat major parasitic diseases

San Francisco, Calif. July 8, 2003 -- The Institute for OneWorld Health, the first nonprofit pharmaceutical company in the United States, announced today it has licensed a novel class of high-potency compounds from Yale University and the University of Washington that could result in medicines for the developing and developed worlds.

The agreement gives OneWorld Health the exclusive license to develop the azole compounds to treat parasitic diseases in the developing world. OneWorld Health will initially focus on the use of the azoles in Chagas disease, the leading cause of heart failure in Latin America, where 16 to 18 million people are infected and another 100 million are at risk. The disease is most often transmitted by an insect known as the "kissing bug," but may also be transmitted by blood transfusion. At least 50,000 to 100,000 people in the U.S. are infected as well.

The licensing agreement also creates a dual market opportunity in which the universities could seek a pharmaceutical partner to develop the same compounds for fungal infections in industrialized countries.

OneWorld Health will conduct appropriate pre-clinical tests after selecting a lead candidate among the compounds, which represent the first new potential drugs to treat Chagas disease in decades. The compounds were developed by teams led by Andrew Hamilton, deputy provost for science and technology at Yale and professor of chemistry, in collaboration with Frederick Buckner, Michael Gelb, Wesley Van Voorhis, and Kohei Yokoyama, all professors at the University of Washington in Seattle.

"We are delighted that these potent anti-Chagas agents have been licensed to an organization that is committed to their development for treatment of this terrible parasitic disease," said Hamilton, of Yale. "We look forward to working with OneWorld Health to produce drug leads that will push these compounds into pre-clinical development and beyond."

"There is more optim
'"/>

Contact: Sedef Onder
sonder@thehaloproject.com
917-570-8934
Institute for OneWorld Health
8-Jul-2003


Page: 1 2 3

Related medicine news :

1. OneWorld Health begins final testing of drug to cure deadly kala azar in India
2. Mailman School of Public Health receives Manhattan Tobacco Cessation Center grant
3. Liverpool to lead 20M Department of Health initiative to develop medicines for children
4. Health care report cards may increase racial/ethnic disparities in bypass operations
5. 2005 Behavioral Sciences & Health Services Research Award
6. Statement on the findings of the Womens Health Study
7. Bone density returns when teens stop using Depo Provera, Group Health study finds
8. Mailman School of Public Health researchers develop infectious disease diagnostic tool
9. Health initiatives can help peace building in the Middle East
10. Study naming hospitals in top 5% for clinical quality released by HealthGrades
11. RelayHealth selected by Columbia University to link doctors and patients online

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:1/18/2017)... ... January 18, 2017 , ... A Palm Beach doctor plans ... Train, an international charity that provides free surgery to poor children suffering from cleft ... the past I have run to support the efforts of the American Heart Association ...
(Date:1/18/2017)... ... January 18, 2017 , ... The Portee Insurance Agency, ... and business owners in central Maryland and the DC region, is inaugurating a charity ... 787,000 people nationally every year, making it the #1 killer in America. However, heart ...
(Date:1/18/2017)... ... 18, 2017 , ... At Hallmark Nameplate, their commitment to quality is what ... to ISO 13485. This certification is another way they are making constant strides to ... that they need. , The ISO 13485 Certification is a major accomplishment for Hallmark ...
(Date:1/18/2017)... ... January 18, 2017 , ... Catalent Pharma Solutions, the ... and consumer health products, today announced that Mr. Michael Merges, Director of Strategic ... to be held at the Mayflower Hotel, Washington DC, on Jan. 24 – ...
(Date:1/18/2017)... Staefa, Switzerland (PRWEB) , ... January 18, 2017 ... ... will for the first time support an aid project with the donation of ... will get the gift of hearing and thus a fair chance of leading ...
Breaking Medicine News(10 mins):
(Date:1/18/2017)... LITTLE FALLS, N.J. , Jan. 18, 2017 /PRNewswire/ ... RGIN ), a biotechnology company specializing in the development ... health of damaged tissues and organs, recently reported the ... key milestones for 2017. As the Company ... 2016 has been a year of substantial accomplishments. The ...
(Date:1/18/2017)...  Dermata Therapeutics, LLC, a biotechnology company developing ... of dermatological diseases, announces dosing the first patient ... 2 acne rosacea study. DMT210 is a topical ... in the skin responsible for the inflammation and ... This clinical trial, DMT210-003, is a 12-week, Phase ...
(Date:1/18/2017)... VILLAGE, Colo. , Jan. 18, 2017 ... independent chain of pharmacies based in Loveland, ... Rx™ Locking Prescription Vials (LPVs) in selected Good Day locations.   ... now have a cost-effective alternative for secure storage," said ... Rx.  "For less than the price of a cup ...
Breaking Medicine Technology:
Cached News: